Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Treasury stock	Retained earnings	Accumulated other comprehensive (loss) income
Beginning of period (in shares) at Sep. 30, 2023		27,466,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		190,000
Treasury shares purchased (in shares)		(186,000)
End of period (in shares) at Mar. 30, 2024		27,470,000
Beginning of period at Sep. 30, 2023	$ 1,214,382	$ 543	$ 661,270	$ (1,134,429)	$ 1,711,328	$ (24,330)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			12,685
Exercise of stock options and vesting of other share-based awards, including tax withholding			(10,825)
Treasury shares purchased				(17,568)
Net income	45,454				45,454
Other comprehensive income (loss)	15,632					15,632
End of period at Mar. 30, 2024	1,259,762	$ 545	663,130	(1,151,997)	1,756,782	(8,698)
Beginning of period (in shares) at Dec. 30, 2023		27,504,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		152,000
Treasury shares purchased (in shares)		(186,000)
End of period (in shares) at Mar. 30, 2024		27,470,000
Beginning of period at Dec. 30, 2023	1,266,755	$ 543	663,542	(1,134,429)	1,740,543	(3,444)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			7,506
Exercise of stock options and vesting of other share-based awards, including tax withholding			(7,918)
Treasury shares purchased				(17,568)
Net income	16,239				16,239
Other comprehensive income (loss)	(5,254)					(5,254)
End of period at Mar. 30, 2024	$ 1,259,762	$ 545	663,130	(1,151,997)	1,756,782	(8,698)
Beginning of period (in shares) at Sep. 28, 2024	27,122,000	27,122,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		171,000
Treasury shares purchased (in shares)		(171,000)
End of period (in shares) at Mar. 29, 2025	27,122,000	27,122,000
Beginning of period at Sep. 28, 2024	$ 1,324,825	$ 545	680,638	(1,190,115)	1,823,143	10,614
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			14,771
Exercise of stock options and vesting of other share-based awards, including tax withholding			(14,529)
Treasury shares purchased				(25,366)
Net income	76,340				76,340
Other comprehensive income (loss)	(24,368)					(24,368)
End of period at Mar. 29, 2025	$ 1,351,675	$ 547	680,880	(1,215,481)	1,899,483	(13,754)
Beginning of period (in shares) at Dec. 28, 2024		27,062,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		146,000
Treasury shares purchased (in shares)		(86,000)
End of period (in shares) at Mar. 29, 2025	27,122,000	27,122,000
Beginning of period at Dec. 28, 2024	$ 1,319,069	$ 545	684,555	(1,202,939)	1,860,410	(23,502)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			7,781
Exercise of stock options and vesting of other share-based awards, including tax withholding			(11,456)
Treasury shares purchased				(12,542)
Net income	39,073				39,073
Other comprehensive income (loss)	9,748					9,748
End of period at Mar. 29, 2025	$ 1,351,675	$ 547	$ 680,880	$ (1,215,481)	$ 1,899,483	$ (13,754)